Please login to the form below
Mark Mallon
This page shows the latest Mark Mallon news and features for those working in and with pharma, biotech and healthcare.
China approves Ironwood Pharma’s IBS treatment
The good news coincides with big changes at the US specialist pharma company, with a new CEO, AstraZeneca's Mark Mallon, and a splitting out into two separate companies. ... Mark Mallon, CEO, Ironwood Pharmaceuticals and Cyclerion. Ironwood and Allergan
Latest news
-
AZ’s Sean Bohen to exit after business overhaul; report
Chief commercial officer Mark Mallon has taken on the CEO role at US biotech Ironwood Pharmaceuticals, while Medimmune research head Bahija Jallal agreed to take the helm of UK biotech company
-
AstraZeneca unveils reorg, hires controversial José Baselga as cancer chief
The reshuffle coincides with the departure of two senior leaders: chief commercial officer Mark Mallon, who leaves to become chief executive of US biotech Ironwood Pharmaceuticals, and Bahija Jallal, who leaves
-
Grünenthal buys Zomig rights as AZ slimming drive continues
Mark Mallon, EVP, global product and portfolio strategy at AstraZeneca, said: “Grünenthal is an established partner with expertise in the treatment of pain.
-
AZ agrees to $320m deal for Zoladex
Mark Mallon, executive vice president of global product and portfolio strategy at AZ, said: “This agreement allows us to retain a significant share of the value of Zoladex in the US
-
AstraZeneca sets sights on China with Takeda deal
The company's executive vice president, international - Mark Mallon - said the increased investment "reinforces our commitment to bring innovative medicines from our exciting pipeline of targeted and biological medicines to patients
More from news
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest Intelligence
-
China: AstraZeneca’s new engine for growth and innovation
AstraZeneca’s Mark Mallon talks to PME about how its long-term investment in China is paying off. " />. ... Mark Mallon is one of the chief architects of AstraZeneca’s current success in China.
-
Biopharma's Future: Made in China
Mark Mallon is executive vice president of Global Product &Portfolio Strategy at AstraZeneca, and before that spent many years as the company’s head of China and then the wider Asia ... AZ's Mark Mallon. “We have built the right culture there,”
More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior Account Manager, Medical Communications, London
-
Excellent package
- Freelance Senior Account Manager / Account Director - Healthcare...
-
£350-400 depending on experience
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
-
Health Consultant - Brand Comms
-
Competitive Salary
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Freelance AM/ AD Healthcare Advertising
-
£350-400 depending on experience
- Scientific Director – Medical Communications
-
Salary TBC
-
Digital Account Director
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Senior Medical Writer
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
Subscribe to our email news alerts
- Blood disorder specialists Imara raises $63m
- NICE wants to stop saying ‘no’ – but needs pharma’s co-operation
- Three questions that should anchor your brand strategy
- Allergy Tx hit hard as birch pollen product stumbles
- Sanofi gets cardio outcomes claim for Praluent in EU
- Keytruda adds another NSCLC approval in Europe
PMHub
Atlantis Healthcare
Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...
Latest intelligence
- “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
- The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
- The Future of Pharma sales: fast forward to 2029
- Change is inevitable, and necessary, for growth in business....
- International Women's Day - 8 March 2019
- International Women's Day has been celebrated since its inception in 1911. But how far have we come?...
Quick links
Infographics
